Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Jassal, Bijay, 2015-01-07
| Class:Id | InstanceEdit:5660943 |
| _displayName | Jassal, Bijay, 2015-01-07 |
| _timestamp | 2015-01-07 17:15:46 |
| author | [Person:73447] Jassal, Bijay |
| dateTime | 2015-01-07 22:11:04 |
| (authored) | [FailedReaction:5660840] Defective SLC6A5 does not cotransport Gly, Cl-, Na+ from extracellular region to cytosol [Homo sapiens] [FailedReaction:5660890] Defective SLC7A9 (in SLC7A9:SLC3A1) does not exchange L-Arg, CySS-, L-Lys for L-Leu [Homo sapiens] [FailedReaction:5660910] Defective SLC7A7 does not exchange L-Arg for L-Leu, Na+ across the plasma membrane [Homo sapiens] |
| (created) | [ReplacedResidue:5660830] L-leucine 334 replaced with L-arginine [Person:5660831] Estivill, X [Person:5660832] Becker, Kristina [EntityFunctionalStatus:5660833] loss_of_function of SLC3A2:SLC7A7 mutants [plasma membrane] [DefinedSet:5660834] SLC6A5 mutants [plasma membrane] [Homo sapiens] [Person:5660835] Lynch, Joseph W [Person:5660836] Incerti, B [ReplacedResidue:5660837] glycine 105 replaced with L-arginine [LiteratureReference:5660838] The impact of human hyperekplexia mutations on glycine receptor structure and function [DefinedSet:5660839] SLC7A9 mutants [plasma membrane] [Homo sapiens] |
| (edited) | [FailedReaction:5660840] Defective SLC6A5 does not cotransport Gly, Cl-, Na+ from extracellular region to cytosol [Homo sapiens] [FailedReaction:5660890] Defective SLC7A9 (in SLC7A9:SLC3A1) does not exchange L-Arg, CySS-, L-Lys for L-Leu [Homo sapiens] [FailedReaction:5660910] Defective SLC7A7 does not exchange L-Arg for L-Leu, Na+ across the plasma membrane [Homo sapiens] |
| (modified) | [Summation:379410] SLC7A7 as a heterodimer with SLC3A2 in the plasma membrane m... [Reaction:379415] SLC7A7:SLC3A2 exchanges L-Arg for L-Leu, Na+ across the plasma membrane [Homo sapiens] [Summation:379439] SLC7A9 as a heterodimer with SLC3A1 in the plasma membrane m... [DefinedSet:444088] SLC6A5,9 [plasma membrane] [Homo sapiens] [CatalystActivity:444119] glycine:sodium symporter activity of SLC6A5,9 [plasma membrane] [Reaction:444120] SLC6A5,9 cotransport Gly, Cl-, Na+ from extracellular region to cytosol [Homo sapiens] [Pathway:5619065] Defective SLC7A9 in vascular wall interactions causes cystinuria (CSNU) [Homo sapiens] [Pathway:5619089] Defective SLC6A5 causes hyperekplexia 3 (HKPX3) [Homo sapiens] [Pathway:5619093] Defective SLC7A7 in vascular wall interactions causes lysinuric protein intolerance (LPI) [Homo sapiens] [Pathway:5619102] SLC transporter disorders [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Jassal, Bijay, 2015-01-07 (5660943)